SCHEMBL5042655

SCHEMBL5042655

CO[C@H](C(=O)NCc1ccc(C#N)cc1)c1ccc(N2CCOCC2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKM P14618 1/20 0.47
SLC1A3 P43003 1/20 0.47
SLC1A2 P43004 1/20 0.47
ALDH1A1 P00352 4/20 0.46
MAPT P10636 4/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
EP300 Q09472 2/20 0.45
ACACB O00763 1/20 0.44
KDM4E B2RXH2 1/20 0.44
GAA P10253 1/20 0.44
ALOX15 P16050 1/20 0.44
ALOX12 P18054 1/20 0.44
MAPK1 P28482 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
EGLN1 Q9GZT9 1/20 0.44
LMNA P02545 1/20 0.43
PANK3 Q9H999 1/20 0.42
RAB9A P51151 1/20 0.42
ERCC1 P07992 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5042653 1.00 PKM (0.47) PKMSLC1A3SLC1A2ALDH1A1MAPT
SCHEMBL5041814 0.92 PKM (0.49) PKMSLC1A3SLC1A2ALDH1A1MAPT
SCHEMBL5041818 0.92 PKM (0.49) PKMSLC1A3SLC1A2ALDH1A1MAPT
SCHEMBL5037994 0.83 HTR1A (0.51) PKMSLC1A3SLC1A2ALDH1A1EP300
SCHEMBL5037992 0.83 HTR1A (0.51) PKMSLC1A3SLC1A2ALDH1A1EP300
Hydrochloric Acid SCHEMBL5037340 0.82 F2 (0.51) PKMALDH1A1MAPTSMN1; SMN2KDM4E
Hydrochloric Acid SCHEMBL5037342 0.82 F2 (0.51) PKMALDH1A1MAPTSMN1; SMN2KDM4E
SCHEMBL5037796 0.81 PKM (0.56) PKMSLC1A3SLC1A2ALDH1A1LMNA
SCHEMBL5037792 0.81 PKM (0.56) PKMSLC1A3SLC1A2ALDH1A1LMNA
SCHEMBL5040508 0.80 PKM (0.72) PKMSLC1A3SLC1A2ALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1567498-B1 MANDELIC ACID DERIVATIVES HOFFMANN LA ROCHE (CH) 2008-01-23 EP disclosed
US-7129238-B2 Mandelic acid derivatives HOFFMANN-LA ROCHE INC. (US) 2006-10-31 US disclosed
EP-1567498-A2 MANDELIC ACID DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2005-08-31 EP disclosed
US-20040122057-A1 Novel mandelic acid derivatives HOFFMANN-LA ROCHE INC. 2004-06-24 US disclosed
WO-2004048335-A2 MANDELIC ACID DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2004-06-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040122057-A1 Novel mandelic acid derivatives F7, F11, F9 PKM 4225/4885SLC1A3 2652/4885SLC1A2 2127/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.